Russell Investments Group
ACHV icon

Russell Investments Group’s Achieve Life Sciences ACHV Stock Holding History

Russell Investments Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6K Buy
6,374
+6,224
+4,149% +$29.7K ﹤0.01% 3663
2026
Q1 		$441 Hold
150
– – ﹤0.01% 4108
2025
Q4 		$746 Hold
150
– – ﹤0.01% 4064
2025
Q3 		$473 Hold
150
– – ﹤0.01% 4080
2025
Q2 		$339 Sell
150
-645
-81% -$1.84K ﹤0.01% 3772
2025
Q1 		$2.12K Sell
795
-2,145
-73% -$6.67K ﹤0.01% 3509
2024
Q4 		$10.3K Buy
2,940
+883
+43% +$4K ﹤0.01% 3127
2024
Q3 		$9.75K Buy
+2,057
New +$9.4K ﹤0.01% 3084

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Russell Investments Group's ACHV Position: Q2 2026 in Review

Russell Investments Group increased its Achieve Life Sciences (ACHV) stake by 4,149% in Q2 2026, buying an estimated $29.7K and bringing the position to 6,374 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

Russell Investments Group first reported a position in ACHV in Q3 2024 and has held it in 8 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Russell Investments Group held 6,374 shares of Achieve Life Sciences worth $41.6K as of Q2 2026.
  • Russell Investments Group bought 6,224 Achieve Life Sciences shares in Q2 2026, an estimated $29.7K.
  • Achieve Life Sciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3663 holding.
  • Russell Investments Group first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.